Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px
Document › Details

Merck KGaA. (8/28/13). "Press Release: James Stewart Appointed Chief Information Officer of Merck". Darmstadt.

Organisations Organisation Merck KGaA
  Group Merck (DE) (Group)
  Organisation 2 Merck (US) (MSD) (Group)
Products Product pharmaceutical
  Product 2 information services
Persons Person Stewart, James (Jim) (Merck (DE) 201803– Head Business Services before CIO joined 2011 before MSD)
  Person 2 Wohlwend, Frédéric (Bertorelli Group 201905 Managing Partner at Forestay Capital before Merck (DE) + Serono)
     


Merck announced today that James Stewart (52) will become Chief Information Officer (CIO) of the Merck Group as of October 1, 2013. In his new position, Stewart will report to Kai Beckmann, member of the Merck Executive Board. Stewart succeeds Frédéric Wohlwend, who has decided to pursue new opportunities outside Merck.

"We thank Frédéric Wohlwend for his many years of service to our company in various leadership positions and we regret his decision to leave Merck. However, we are pleased to have appointed James Stewart, a highly qualified and experienced manager, to succeed him," said Kai Beckmann, whose Executive Board responsibilities include Group Information Services.

James Stewart joined the Merck Serono biopharmaceutical division in 2011 and has made important contributions to both the development of the pharmaceutical business and the transformation of Merck as a whole. Prior to joining Merck, he had a long and successful career with MSD (in the U.S.: Merck & Co.), where he started in Human Resources and progressed through several global business and functional leadership roles that resulted in organizational turnarounds through business process improvements and operation excellence programs.

Stewart moved to Europe in 2001 to take on the position of Executive Director and International CIO at MSD, spanning EMEA, Canada, Latin America and Asia- Pacific. He then joined the Human Health division of the same company in 2007 and led a successful business transformation program across the EMEA region. In 2009, he was appointed Vice President and Program Realization Officer within the Emerging Markets business unit, where he led the efforts to develop and implement a business acceleration strategic plan.

Stewart completed his university education in New York and New Jersey (USA), obtaining Masters of Business Administration degrees in Finance and Managerial Sciences, following a Bachelor of Science in Information Systems and Business Administration.


All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.

Merck is a leading pharmaceutical, chemical and life science company with total revenues of € 11.2 billion in 2012, a history that began in 1668, and a future shaped by approx. 38,000 employees in 66 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

   
Record changed: 2019-10-06

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Merck (DE) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75




» top